Apex Biotechnology Corp. · TWSE:1733
Apex Biotechnology — Investor Conference (December 2025)
12 slides from Apex Biotechnology's conference presentation, Dec 24, 2025
Slide 1: Dec 2025
BS Taiwan Dec 2025
Slide 2: Company profile
Company profile TSEC 1733 Industry IVD Medical Device Operation Locations .Head quarter: No. 7, Li-Hsin 5th Rd., Hsinchu Science Park, Hsinchu, Taiwan .Tao Yuan Factory: No. 180, Lane 70, Wuqing Rd., Dayuan Dist., Taoyuan City, Taiwan .Suzhou Corp.: Room 106, No.2, Kecheng Road, SIP, Suzhou, China .
Slide 3: Milestone
Milestone 1997-2001 2002-2006 2007-2011 1997 ApexBio set-up 2002 ISO9001/13485 Notified 2009 Taoyuan factory set-up 1998 BGM FDA 510K approval 2003 CE IVDD notified 2011 AEO certified by Customs Admin 2001 Transit IPO listed to TSEC 2004 Taiwan GMP notified 2011 3rd time FDA on-site inspection 2001
Slide 4: Quality System
Quality System Region The Authority Regulatory compliance Taiwan TFDA QMS ISO 13485:2016 EU CE CE mark number:CE0197 EN ISO 15197:2015 Quality System Regulation (21 CFR Part 820) USA FDA 510K’s on-site audit w/o 483 citations 2023 MDSAP (USA/Canada/Brazil) China NMPA Medical Device Class II 2017 pas
Slide 5: Product Series
[ Product Series | DIABETES CARE HOME DIAGNOSTICS CLINICAL & LABORATORY POINT-OF-CARE
Slide 6: Home diagnostics products
{ Home diagnostics products |
Slide 7: New pipeline product
New pipeline product ◼ Rapid test TFDA QMS passed • COVID-19 Antigen Rapid Test Kit • KP Rapid Test Kit • Influenza Rapid Test Kit Developing items: • Vector-borne Disease Detection for Mosquito-borne Illnesses • Economic Animal and Animal Epidemic Prevention Detection • DOA ◼ Home use CGM 7
Slide 8: Global sales distribution
8Global sales distribution Territory 2023 2024 2025/1-3Q America 41% 39% 48% EU 44% 48% 43% Asia 13.5% 12% 8% Africa 1.5% 1% 1%
Slide 9: Finance Performance
Finance Performance 2023 2024 2025/1-3Q Revenue 1,676,537 1,852,211 1,505,913 Gross margin 531,116 521,342 406,378 Operation profit 141,716 128,464 107,485 Profit after tax 115,714 128,104 112,837 EPS 1.16 1.28 1.13 G/M ratio 31% 28% 27% Shipped Meter Qty (kit) 1,189K 1,368K 953K Shipped Strip Qty (
Slide 10: Product ratio
Product ratio 2024 2025/1-3Q 4% 5% 15% BGM & A1C 12% BGM & A1C 2% Electrode Electrode 6% Non-BGM Non-BGM Others Others 74% 82% Non-BGM Hemoglobin/Ketone/Uric Acid/Lactate/Cholesterol/ Pesticide quick check etc.
Slide 11: The 11th Corporate Governance Evaluation (2024)
the 11th Corporate Governance Evaluation (2024) Points for Number of AA/A+ Total number of Distribution Category satisfied inapplicable Extra Credit indicators weight indicators indicators Indicators Year 2023 2024 2023 2024 2023 2024 2023 2024 2023 2024 Protecting Shareholder Rights and Interests a
Slide 12: Thank you
Thank you BAS 2h Taiwan
Apex Biotechnology — Investor Conference (December 2025) on 6ix